Scarica l'app Stockscreener
2.25
8.17%
0.17
Dopo l'orario di chiusura:
2.05
-0.20
-8.89%
Sunshine Biopharma Inc Borsa (SBFM) Ultime notizie
Sunshine Biopharma Reports 78% Revenue Growth and Key Developments in 2022 - TipRanks
Sunshine Biopharma (SBFM) Secures $2.46 Million in Direct Stock Offering - GuruFocus
Sunshine Biopharma secures $2.46 million in stock offering - Investing.com
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - ACCESS Newswire
$2.46M Institutional Investment: Sunshine Biopharma Announces Strategic Direct Offering - Stock Titan
Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Benzinga
Biotech Stock Sunshine Biopharma Inc. (NASDAQ:SBFM) Makes NASDAQ Top Gainer List on News - Investorideas.com
Sunshine Biopharma reports progress in liver cancer treatment - Investing.com India
Sunshine Biopharma (SBFM) Announces Promising Results for Liver Cancer Treatment - GuruFocus
Sunshine Biopharma Completes Additional Studies of mRNA Therapy for Liver Cancer; Shares Up Pre-Bell - MarketScreener
Pre-market Movers: IBG, JYD, SBFM, SPWH, RSLS… - RTTNews
Revolutionary mRNA Treatment Succeeds Against Deadly Liver Cancer in Latest Trial - Stock Titan
Sunshine Biopharma (SBFM) Reports Increased Revenue Despite Net Loss - GuruFocus
Sunshine Biopharma (SBFM) Reports 2024 Financial Highlights - GuruFocus
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year - ACCESS Newswire
Sunshine Biopharma Reports Record Revenue: 13 New Drugs and Cancer Treatment Breakthrough - Stock Titan
Sunshine Biopharma Inc. SEC 10-K Report - TradingView
Sunshine Biopharma (SBFM) Stock Soars In Pre-Market Trading - Stocks Telegraph
Sunshine Biopharma Inc expected to post earnings of 11 cents a shareEarnings Preview - TradingView
Sunshine Biopharma signs agreement for rights to market two generic antibiotics - Yahoo Finance
Sunshine Biopharma to market new antibiotics in Canada By Investing.com - Investing.com Australia
Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada - MSN
Sunshine Biopharma to market new antibiotics in Canada - Investing.com India
Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada - Yahoo Finance
Major Antibiotics Deal: Sunshine Biopharma Expands Portfolio in Billion-Dollar Market - Stock Titan
Sunshine Biopharma stock hits 52-week low at $2.01 By Investing.com - Investing.com Australia
Sunshine Biopharma stock hits 52-week low at $2.01 - Investing.com India
Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 0.5% – Should You Sell? - Defense World
Sunshine Biopharma expands with new gastrointestinal drug By Investing.com - Investing.com Canada
Sunshine Biopharma expands with new gastrointestinal drug - Investing.com India
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market - ACCESS Newswire
Sunshine Biopharma stock hits 52-week low at $2.09 By Investing.com - Investing.com Australia
Sunshine Biopharma stock hits 52-week low at $2.09 - Investing.com India
A Look at Sunshine Biopharma Inc (SBFM) Shares in the Recent Past Indicates Growth - SETE News
Sunshine Biopharma (NASDAQ:SBFMW) Trading 30% Higher – Should You Buy? - Defense World
Sunshine Biopharma Announces Reverse Stock Split - ACCESS Newswire
Sunshine Biopharma Launches Two New Generic Prescription Drugs - ACCESS Newswire
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) - ACCESS Newswire
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - ACCESS Newswire
Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga
Who’s Hired? Haruvi Returns For A Second Term As AAM Chair - News & Insights
Sunshine Biopharma launches Olanzapine and Olanzapine ODT - Indian Pharma Post
Sunshine Biopharma introduces new generic drugs in Canada - MSN
Sunshine Biopharma Appoints New Chief Commercial Officer - MSN
Sunshine Biopharma Launches Generic Mental Health Drug in Rapidly Growing Canadian Market - StockTitan
Sunshine Biopharma Appoints Michel Roy as Chief Commercial Officer - Defense World
Sunshine Biopharma appoints Michel Roy as CCO - MSN
Sunshine Biopharma names new Chief Commercial Officer By Investing.com - Investing.com South Africa
Sunshine Biopharma names new Chief Commercial Officer - Investing.com
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer - WICZ
4.06%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):